Early Neuromuscular Blockade in Moderate-to-Severe Pediatric Acute Respiratory Distress Syndrome.,Critical Care Medicine

当前位置： X-MOL 学术 › Crit. Care Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Early Neuromuscular Blockade in Moderate-to-Severe Pediatric Acute Respiratory Distress Syndrome.
Critical Care Medicine ( IF 7.7 ) Pub Date : 2022-01-06 , DOI: 10.1097/ccm.0000000000005426
Michelle W Rudolph ₁ , Martin C J Kneyber _{1,

2} , Lisa A Asaro ₁ , Ira M Cheifetz ₁ , David Wypij _{3,

4,

5} , Martha A Q Curley _{6,

7,

8} ,

Affiliation

The use of neuromuscular blocking agents (NMBAs) in pediatric acute respiratory distress syndrome (PARDS) is common but unsupported by efficacy data. We sought to compare the outcomes between patients with moderate-to-severe PARDS receiving continuous NMBA during the first 48 hours of endotracheal intubation (early NMBA) and those without.

中文翻译：

中度至重度小儿急性呼吸窘迫综合征的早期神经肌肉阻滞。

神经肌肉阻滞剂（NMBA）在小儿急性呼吸窘迫综合征（PARDS）中的使用很常见，但没有疗效数据支持。我们试图比较中重度 PARDS 患者在气管插管的前 48 小时内接受连续 NMBA（早期 NMBA）和未接受连续 NMBA 的患者的结果。

更新日期：2022-01-06

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11